BARCLAYS PLC - MIRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,452
+27.2%
299,120
+4.2%
0.01%
+20.0%
Q2 2023$7,429
+3.3%
287,150
-4.1%
0.01%
+66.7%
Q1 2023$7,193
-2.3%
299,463
-20.7%
0.00%0.0%
Q4 2022$7,363
-99.6%
377,572
+324.8%
0.00%
+50.0%
Q3 2022$1,867,000
+312.1%
88,877
+282.2%
0.00%
Q2 2022$453,000
-29.9%
23,256
-20.7%
0.00%
-100.0%
Q1 2022$646,00029,3190.00%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,921,118$38,269,0006.42%
FRAZIER MANAGEMENT LLC 3,566,912$71,053,0005.68%
Novo Holdings A/S 2,445,147$48,707,0002.52%
Sio Capital Management, LLC 248,978$4,960,0001.58%
Mesirow Financial Investment Management, Inc. 25,795$514,0001.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,282,912$65,396,0001.28%
NEA Management Company, LLC 4,187,801$83,421,0000.99%
MPM BioImpact LLC 308,532$6,146,0000.95%
Rock Springs Capital Management LP 1,525,623$30,390,0000.64%
BVF INC/IL 435,936$8,684,0000.34%
View complete list of MIRUM PHARMACEUTICALS INC shareholders